As previously discussed by Foley Hoag’s attorneys in its Cannabis practice, a rescheduling of cannabis from a Schedule I Controlled Substance to a Schedule III Controlled Substance will provide cannabis businesses with the...more
This is our eighth and final post in our First 100 Days series examining important trends in white collar law and investigations in the early days of the Biden administration. Our previous entry was on pandemic-related fraud....more
Businesses in chapter 11 bankruptcy cases were barred from receiving federal loans under the Paycheck Protection Program (“PPP”), part of Congress’s Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The...more
Editors’ Note: This is the fourth in our start-of-year series examining important trends in white collar law and investigations in the coming year. Our previous entry discussed anti-corruption trends in 2020. Up next: a look...more
1/16/2020
/ Buy American Act ,
Compliance ,
Cooperation ,
Corporate Liability ,
Criminal Liability ,
Cybersecurity ,
Department of Justice (DOJ) ,
Dismissals ,
Enforcement ,
Enforcement Actions ,
Enforcement Statistics ,
False Claims Act (FCA) ,
False Implied Certification Theory ,
Federal Contractors ,
Health Care Providers ,
Implied Certification ,
Materiality ,
Medicaid ,
Popular ,
Private Equity ,
Split of Authority ,
Tariffs ,
The Granston Memo ,
Trump Administration ,
Universal Health Services Inc v United States ex rel Escobar
In United States ex rel. Kraus v. Wells Fargo & Co., No. 18-1746 (2d Cir. Nov. 21, 2019), two employees of banks later acquired by Wells Fargo alleged a “pervasive pattern” of fraud in connection with the securitization and...more
On September 18, 2019, the Department of Justice announced a $21.36 million settlement to resolve a False Claims Act (“FCA”) lawsuit alleging a fraudulent kickback scheme through which a pharmaceutical company (Patient Care...more
10/3/2019
/ Department of Justice (DOJ) ,
False Claims Act (FCA) ,
Health Care Providers ,
Healthcare Fraud ,
Investors ,
Kickbacks ,
Life Sciences ,
Medical Reimbursement ,
Pharmaceutical Industry ,
Pharmacies ,
Physicians ,
Portfolio Companies ,
Prescription Drugs ,
Private Equity Firms ,
Settlement ,
Telemedicine ,
Veterans
Private Equity Firm Settles Federal False Claims Act Suit Regarding Compounding Pharmacy It Managed -
On September 18, 2019, the Department of Justice announced a $21.36 million settlement to resolve a False Claims Act...more
On September 7, 2018, the Massachusetts Supreme Judicial Court refused to enforce a non-competition and non-solicitation agreement between a Massachusetts company and its California-based former employee who joined the...more